The rate of progression in Parkinson's disease:: A [18F]dopa PET study

被引：0
|
作者：
Nurmi, EM
Ruottinen, HM
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
机构：
来源：
NEUROLOGY | 1999年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A91 / A91
页数：1
相关论文
共 50 条
  • [41] The role of the deep convolutional neural network as an aid to interpreting brain [18F]DOPA PET/CT in the diagnosis of Parkinson’s disease
    Arnoldo Piccardo
    Roberto Cappuccio
    Gianluca Bottoni
    Diego Cecchin
    Luca Mazzella
    Alessio Cirone
    Sergio Righi
    Martina Ugolini
    Pietro Bianchi
    Pietro Bertolaccini
    Elena Lorenzini
    Michela Massollo
    Antonio Castaldi
    Francesco Fiz
    Laura Strada
    Angelina Cistaro
    Massimo Del Sette
    European Radiology, 2021, 31 : 7003 - 7011
  • [42] PET imaging of mGluR5 with [18F]FPEB in Parkinson's disease
    Kang, Y.
    He, B.
    Verma, A.
    Henchcliffe, C.
    Kothari, P. J.
    Schlyer, D.
    Schmidt, K.
    Chiao, P. C.
    Vallabhajosula, S.
    Mozley, P. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S194 - S194
  • [43] The role of the deep convolutional neural network as an aid to interpreting brain [18F]DOPA PET/CT in the diagnosis of Parkinson's disease
    Piccardo, Arnoldo
    Cappuccio, Roberto
    Bottoni, Gianluca
    Cecchin, Diego
    Mazzella, Luca
    Cirone, Alessio
    Righi, Sergio
    Ugolini, Martina
    Bianchi, Pietro
    Bertolaccini, Pietro
    Lorenzini, Elena
    Massollo, Michela
    Castaldi, Antonio
    Fiz, Francesco
    Strada, Laura
    Cistaro, Angelina
    Del Sette, Massimo
    EUROPEAN RADIOLOGY, 2021, 31 (09) : 7003 - 7011
  • [44] Cerebral[18F]FDG PET in the diagnosis of Atypical Parkinson Disease - a retrospective study
    Houssein, N.
    Marner, L.
    Hejl, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S212 - S213
  • [45] Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma
    Martiniova, Lucia
    Cleary, Susannah
    Lai, Edwin W.
    Kiesewetter, Dale O.
    Seidel, Jurgen
    Dawson, Linda F.
    Phillips, Jacqueline K.
    Thomasson, David
    Chen, Xiaoyuan
    Eisenhofer, Graeme
    Powers, James F.
    Kvetnansky, Richard
    Pacak, Karel
    NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (02) : 215 - 226
  • [46] Longitudinal comparison of 11C-PE2I and 18F-DOPA pet for assessing severity and rate of disease progression in patients with Parkinson's disease
    Li, W.
    Lao-Kaim, N. P.
    Roussakis, A.
    Martin-Bastida, A.
    Loane, C.
    Valle-Guzman, N.
    Kefalopoulou, Z.
    Politis, M.
    Foltynie, T.
    Barker, R. A.
    Piccini, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 128 - 128
  • [47] Longitudinal comparison of 11C-PE2I and 18F-DOPA PET for assessing severity and rate of disease progression in patients with Parkinson's disease
    Li, W.
    Lao-Kaim, N.
    Roussakis, A. -A.
    Martin-Bastida, A.
    Loane, C.
    Valle-Guzman, N.
    Kefalopoulou, Z.
    Politis, M.
    Foltynie, T.
    Barker, R.
    Piccini, P.
    MOVEMENT DISORDERS, 2017, 32
  • [48] The neurobiology of treatment resistant and responsive schizophrenia: an [18F]DOPA PET study
    Kim, E.
    Howes, O.
    Kwon, J. S.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2017, 37 : 233 - 234
  • [49] Progression in Parkinson's disease:: A positron emission tomography study with a dopamine transporter ligand [18F] CFT
    Nurmi, E
    Ruottinen, HM
    Kaasinen, V
    Bergman, J
    Haaparanta, M
    Solin, O
    Rinne, JO
    ANNALS OF NEUROLOGY, 2000, 47 (06) : 804 - 808
  • [50] A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease
    Hu, MTM
    White, SJ
    Herlihy, AH
    Chaudhuri, KR
    Hajnal, JV
    Brooks, DJ
    NEUROLOGY, 2001, 56 (09) : 1195 - 1200
12345